Fructose
As of the edition of 20 October 2026, Fructose is a small molecule: marketed, first approved in 1998 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1998
- Kind
- Small molecule
- Brand name
- Levulose Biosedra
- First approved
- 9 February 1998 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Fresenius Kabi
- Registered trials
- 6, 1 stopped early
- Disease areas
- Nervous system; Pregnancy and women's health; Urinary and reproductive; Blood and lymph; Heart and blood vessels; Hormones
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 1 | 1 | 1 | 0 | 0 |
| Phase 2 | 2 | 0 | 1 | 1 |
| Phase 3 | 2 | 0 | 0 | 0 |
| All trials | 6 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Gilead Sciences | Lead sponsor of trials | 2015 to now |